CORE--LABORATORY FACILITY

$0P01FY2002AINIH

University Of Florida, Gainesville FL

Investigators

Linked publications & trials

Paper 39763971 Paper 39704278 Paper 39694914 Paper 39678192 Paper 39345402 Paper 38621411 Paper 38405840 Paper 38308004 Paper 38187768 Paper 38117999 Paper 38117469 Paper 38079221 Paper 37888801 Paper 37594278 Paper 37498686 Paper 37460638 Paper 37432736 Paper 37332366 Paper 37267353 Paper 37237059 Paper 36778468 Paper 36549505 Paper 36249412 Paper 36082558 Paper 35878027 Paper 35757772 Paper 35247306 Paper 35043156 Paper 35025103 Paper 34890254 Paper 34858326 Paper 34806648 Paper 34799406 Paper 34731614 Paper 34721308 Paper 34620616 Paper 34611019 Paper 34603322 Paper 34535154 Paper 34484194 Paper 34380694 Paper 34326233 Paper 34301848 Paper 34156979 Paper 34127860 Paper 34035041 Paper 33940160 Paper 33900291 Paper 33841327 Paper 33717184 Paper 33658296 Paper 33632743 Paper 33632742 Paper 33545036 Paper 33532620 Paper 33496819 Paper 33483996 Paper 33478573 Paper 33472941 Paper 33471743 Paper 33441381 Paper 33419759 Paper 33323126 Paper 33307036 Paper 33207244 Paper 33193362 Paper 33113547 Paper 33021571 Paper 33007439 Paper 32894306 Paper 32868408 Paper 32867274 Paper 32833543 Paper 32634859 Paper 32587885 Paper 32573495 Paper 32351504 Paper 32229538 Paper 32035746 Paper 31959869 Paper 31862821 Paper 31826866 Paper 31753960 Paper 31669629 Paper 31471352 Paper 31309537 Paper 31221801 Paper 31167894 Paper 31160534 Paper 31145130 Paper 31118934 Paper 30967424 Paper 30920391 Paper 30843680 Paper 30830416 Paper 30713109 Paper 30528099 Paper 30065030 Paper 29894743 Paper 29527189

Abstract

This Core will serve as the laboratory component for the program project, a unit that will serve all three projects through a combination of immunologic and genetic determinations. Dr. She (core leader) and Dr. McIndoe (co-core leader) will provide scientific management of this core. The goals of this core will be: 1. To measure autoantibodies commonly associated with or have predictive value for type 1 diabetes: GADA, IA2-A for human and IAA for mice. 2. To provide information ascribing genetic susceptibility by HLA-DR and -DR genotyping. 3. To measure gene expression levels for immune-related genes using the high throughput cDNA microarray technologi

View original record on NIH RePORTER →